UnitedHealth Got a Boost From Berkshire’s Buying. 2 Reasons to Wait to Follow. UnitedHealth Group, the worst-performing stock in the Dow Jones Industrial Average so far this year, got a major boost last week from billionaire investor Warren Buffett. That doesn’t mean everyone else should buy.

Following an investment by Warren Buffett's Berkshire Hathaway, many eyes are on the healthcare insurer these days.

NEW YORK] The Warren Buffett effect is proving true once again, spurring UnitedHealth Group’s reversal this month and giving the Dow Jones Industrial Average a push towards its first closing high since last year.

Shares of UnitedHealth Group are surging before the market open Friday as Warren Buffett’s Berkshire Hathaway disclosed that it recently purchased shares of the beleaguered insurer

This investment signifies Buffett's re-entry into UNH after liquidating his entire position back in 2010, indicating that he perceives significant value at

The company may be under criminal investigation for alleged irregularities in its Medicare business—but it's been touched by the Warren Buffett effect.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.

UnitedHealth Group ( UNH 12.04%) has been a solid dividend growth stock for years. Generally, its yield has been fairly low, due to the stock's rising value. Even as the healthcare insurance giant has grown its dividend, its yield hasn't been particularly high or noteworthy.

Year to date, the stock has fallen by nearly 45%, which is by no means normal for the healthcare stock. In fact, this is the worst it has performed since the Great Recession, when it tumbled by more than 54% in 2008.

The seller was Amulet Capital Partners L.P., a private equity firm based in Greenwich, Conn. Amulet founded U.S. Digestive Health in 2019. The sale price to UnitedHealth was not disclosed.